These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 32488051)

  • 1. Diagnosis of NTM active infection in lymphadenopathy patients with anti-interferon-gamma auto-antibody using inhibitory ELISA vs. indirect ELISA.
    Nithichanon A; Chetchotisakd P; Matsumura T; Takahashi Y; Ato M; Sakagami T; Lertmemongkolchai G
    Sci Rep; 2020 Jun; 10(1):8968. PubMed ID: 32488051
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum Anti-interferon-γ Autoantibody Titer as a Potential Biomarker of Disseminated Non-tuberculous Mycobacterial Infection.
    Yoshizawa K; Aoki A; Shima K; Tanabe Y; Koya T; Hasegawa T; Kikuchi T; Sakagami T
    J Clin Immunol; 2020 Feb; 40(2):399-405. PubMed ID: 32034574
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autoantibody to interferon-gamma associated with adult-onset immunodeficiency in non-HIV individuals in Northern Thailand.
    Wongkulab P; Wipasa J; Chaiwarith R; Supparatpinyo K
    PLoS One; 2013; 8(9):e76371. PubMed ID: 24086734
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-tuberculous mycobacterial infection and reactive dermatosis associated with adult-onset immunodeficiency due to anti-interferon-gamma autoantibodies: A case report.
    Liang XN; Bin YF; Lai GT; Li YH; Zhang JQ; Zhong XN; Bai J; Li MH; Deng JM; He ZY
    Medicine (Baltimore); 2020 Sep; 99(36):e21738. PubMed ID: 32899003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distinct Lymphocyte Immunophenotyping and Quantitative Anti-Interferon Gamma Autoantibodies in Taiwanese HIV-Negative Patients with Non-Tuberculous Mycobacterial Infections.
    Lee WI; Fang YF; Huang JL; You HL; Hsieh MY; Huang WT; Liang CJ; Kang CC; Wu TS
    J Clin Immunol; 2023 May; 43(4):717-727. PubMed ID: 36624329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disseminated nontuberculous mycobacterial infection in a patient with idiopathic CD4 lymphocytopenia and IFN-γ neutralizing antibodies: a case report.
    Goto R; Shiota S; Kaimori R; Horinouchi N; Utsunomiya Nishimizu R; Yamamoto K; Miyazaki E
    BMC Infect Dis; 2023 Jan; 23(1):58. PubMed ID: 36717786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disseminated Mycolicibacter arupensis and Mycobacterium avium co-infection in a patient with anti-interferon-γ neutralizing autoantibody-associated immunodeficiency syndrome.
    Hirayama K; Kanda N; Suzuki T; Sasaki K; Kimura Y; Takahashi K; Matsumura M; Hatakeyama S
    J Infect Chemother; 2022 Sep; 28(9):1336-1339. PubMed ID: 35691862
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical outcome and laboratory markers for predicting disease activity in patients with disseminated opportunistic infections associated with anti-interferon-γ autoantibodies.
    Angkasekwinai N; Suputtamongkol Y; Phoompoung P; Pithukpakorn M; Wongswat E; Umrod P; Tongsai S; Foongladda S
    PLoS One; 2019; 14(4):e0215581. PubMed ID: 31022229
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors associated with acquired Anti IFN- γ autoantibody in patients with nontuberculous mycobacterial infection.
    Phoompoung P; Ankasekwinai N; Pithukpakorn M; Foongladda S; Umrod P; Suktitipat B; Mahasirimongkol S; Kiertiburanakul S; Suputtamongkol Y
    PLoS One; 2017; 12(4):e0176342. PubMed ID: 28437431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical Significance of Interferon-γ Neutralizing Autoantibodies Against Disseminated Nontuberculous Mycobacterial Disease.
    Aoki A; Sakagami T; Yoshizawa K; Shima K; Toyama M; Tanabe Y; Moro H; Aoki N; Watanabe S; Koya T; Hasegawa T; Morimoto K; Kurashima A; Hoshino Y; Trapnell BC; Kikuchi T
    Clin Infect Dis; 2018 Apr; 66(8):1239-1245. PubMed ID: 29126235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of QuantiFERON-TB Gold In-tube assay in screening for neutralizing anti-interferon-γ autoantibodies in patients with disseminated nontuberculous mycobacterial infection.
    Wu UI; Chuang YC; Sheng WH; Sun HY; Jhong YT; Wang JY; Chang SC; Wang JT; Chen YC
    Clin Microbiol Infect; 2018 Feb; 24(2):159-165. PubMed ID: 28694201
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel assay to detect increased level of neutralizing anti-interferon gamma autoantibodies in non-tuberculous mycobacterial patients.
    Shima K; Sakagami T; Tanabe Y; Aoki N; Moro H; Koya T; Kagamu H; Hasegawa T; Suzuki E; Narita I
    J Infect Chemother; 2014 Jan; 20(1):52-6. PubMed ID: 24462426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-interferon-γ autoantibody and opportunistic infections: case series and review of the literature.
    Kampitak T; Suwanpimolkul G; Browne S; Suankratay C
    Infection; 2011 Feb; 39(1):65-71. PubMed ID: 21128092
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disseminated Mycobacterium abscessus subsp. massiliense infection in a Good's syndrome patient negative for human immunodeficiency virus and anti-interferon-γ autoantibody: a case report.
    Imoto W; Yamada K; Hajika Y; Okamoto K; Myodo Y; Niki M; Kuwabara G; Yamairi K; Shibata W; Yoshii N; Nakaie K; Yoshizawa K; Namikawa H; Watanabe T; Asai K; Moro H; Kaneko Y; Kawaguchi T; Itoh Y; Kakeya H
    BMC Infect Dis; 2020 Jun; 20(1):431. PubMed ID: 32563248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Juvenile-Onset Immunodeficiency Secondary to Anti-Interferon-Gamma Autoantibodies.
    Liew WK; Thoon KC; Chong CY; Tan NWH; Cheng DT; Chan BSW; Ng MSY; Das L; Arkachaisri T; Huang CH; Kuan JL; Chai LYA; Koh MJA
    J Clin Immunol; 2019 Jul; 39(5):512-518. PubMed ID: 31177358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simultaneous disseminated infections with intracellular pathogens: an intriguing case report of adult-onset immunodeficiency with anti-interferon-gamma autoantibodies.
    Roerden M; Döffinger R; Barcenas-Morales G; Forchhammer S; Döbele S; Berg CP
    BMC Infect Dis; 2020 Nov; 20(1):828. PubMed ID: 33176707
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disseminated Mycobacterium haemophilum skeletal disease in a patient with interferon-gamma deficiency.
    Otome O; O'Reilly M; Lim L
    Intern Med J; 2015 Oct; 45(10):1073-6. PubMed ID: 26429217
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incorrect diagnoses in patients with neutralizing anti-interferon-gamma-autoantibodies.
    Wu UI; Wang JT; Sheng WH; Sun HY; Cheng A; Hsu LY; Chang SC; Chen YC
    Clin Microbiol Infect; 2020 Dec; 26(12):1684.e1-1684.e6. PubMed ID: 32120037
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disseminated Mycobacterium avium complex infection mimicking malignancy in a patient with anti-IFN-γ autoantibodies: a case report.
    Yeh YK; Ding JY; Ku CL; Chen WC
    BMC Infect Dis; 2019 Oct; 19(1):909. PubMed ID: 31664931
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Subcutaneous injection of interferon gamma therapy could be useful for anti-IFN-γ autoantibody associated disseminated nontuberculous mycobacterial infection.
    Harada M; Furuhashi K; Karayama M; Suzuki Y; Hozumi H; Enomoto N; Fujisawa T; Nakamura Y; Inui N; Suda T
    J Infect Chemother; 2021 Feb; 27(2):373-378. PubMed ID: 33071037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.